High risk genes predisposing to prostate cancer development do they exist?

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 4, 2000, Pages 241-247

  Singh, R ^a   Eeles, R A ^a,b   Durocher, F ^c   Simard, J ^c   Edwards, S ^a   Badzioch, M ^d   Kote Jarai, Z ^a   Teare, D ^e   Ford, D ^a   Dearnaley, D ^a,b   Ardern Jones, A ^b   Murkin, A ^b   Dowe, A ^b   Shearer, R ^b   Kelly, J ^a   Labrie, F ^c   Easton, D ^e   Narod, S A ^f   Tonin, P N ^c   Foulkes, W D ^g  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

^g MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Genetics; High risk genes; Low risk genes; Prostate cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILIAL CANCER; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE;

EID: 0034511632     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500478     Document Type: Article

References (69)

1. Epidemiology of prostate cancer
2. Estimates of the worldwide incidence of 18 major cancers in 1985
3. Family history and prostate cancer risk in black, white and Asian men in the United States and Canada
4. Recherches clinico-statistiques et génétiques sur les néoplasies de la prostate
5. An investigation of the familial aspects of carcinoma of the prostate
6. Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy
7. Genetic predisposition to prostate cancer
8. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands
9. Familial prostate cancer in Sweden
10. Family history and the risk of prostate cancer
11. Mendelian inheritance of familial prostate cancer
12. Studies of genetic factors in prostate cancer in a twin population
13. Evidence for autosomal dominant inheritance of prostate cancer
14. Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance
15. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
16. Linkage of early-onset familial breast cancer to chromosome 17q21
17. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
18. Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5
19. Genetic mapping of a locus predisposing to human colorectal cancer
20. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome wide search
21. International Consortium for Prostate Cancer Genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics
22. International Consortium for Prostate Cancer Genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics
23. Linkage analysis of chromosome 1q markers in 136 prostate cancer families
24. Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study
25. Re: Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study
26. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees
27. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer
28. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25
29. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus
30. Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1
31. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43
32. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer
33. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer
34. No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE Consortium
35. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36
36. Evidence for a prostate cancer susceptibility locus on the X chromosome
37. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX
38. Evidence for a prostate cancer susceptibility locus on chromosome 20
39. A genome screen of multiplex sibships with prostate cancer
40. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma
41. Allelic loss of chromosomes 16q and 10q in human prostate cancer
42. A genomic scan of families with prostate cancer families identifies multiple regions of interest
43. Concerning a familial association between breast cancer and both prostatic and uterine malignancies
44. Breast cancer risks in relatives of male breast cancer patients
45. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer
46. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer
47. Risks of cancer in BRCA1-mutation carriers
48. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
49. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
50. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium
51. Germ-line BRCA1 mutations in selected men with prostate cancer
52. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity
53. Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate
54. The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species
55. Mapping of the HSD17B2 gene encoding type II 17b-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2
56. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behaviour of prostate cancer
57. Structure of the human type II 5α-reductase gene
58. Mapping of the steroid 5α-reductase type 2 (SRD5A2) gene close to D2S352 on chromosome 2p22-23 region
59. 5-α-reductase activity and risk of prostate cancer among Japanese and US white and black males
60. A prevalent missense substitution that modulates activity of prostate steroid 5a-reductase
61. No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
62. Strategies for multilocus linkage analysis in humans
63. Parametric and nonparametric linkage analysis: A unified multipoint approach
64. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer
65. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus